AADR vs CHNA

AADR is an ETF, whereas CHNA is a mutual fund. AADR has a higher expense ratio than CHNA (1.1% vs 0.79%). Below is the comparison between AADR and CHNA.

AADR CHNA
Security Type ETF Mutual fund
Segment Equity: Global Ex-U.S. - Total Market Growth N/A
Issuer AdvisorShares Loncar Investments
Net Assets $69.25M $10.5M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive
Dividend Yield 0.68% 0.15%
Minimum Investment N/A N/A
YTD Return -13.66% 3.56%
1-Year Return 3.18% 14.67%
3-Year Return -1.15% N/A
5-Year Return 3.36% N/A
10-Year Return N/A N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return -13.66%
1-Month Return 6.91%
3-Month Return -17.61%
1-Year Return 3.18%
3-Year Return -1.15%
5-Year Return 3.36%
10-Year Return N/A
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (41.23% of Total Assets)

Name Symbol % Assets
Galapagos NV ADR GLPG 6.19%
NICE Ltd ADR NICE 5.42%
argenx SE ADR ARGX 4.32%
ZTO Express (Cayman) Inc ADR ZTO 4.04%
TAL Education Group ADR TAL 3.83%
MercadoLibre Inc MELI.SA 3.82%
Anglogold Ashanti Ltd ADR AU.JO 3.45%
ASML Holding NV ADR ASML 3.42%
AstraZeneca PLC ADR AZN.L 3.38%
Gold Fields Ltd ADR GFI.JO 3.36%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

CHNA description

The Fund seeks to track the performance of the Loncar China BioPharma Index. The Fund invests at least 80% of its assets in the component securities of the Index constructed from the universe of Nasdaq- or Hong Kong Stock Exchange-listed companies identified by the Index methodology as Biopharma Companies.

CHNA performance & returns

YTD Return 3.56%
1-Month Return 7.39%
3-Month Return -1.80%
1-Year Return 14.67%
3-Year Return N/A
5-Year Return N/A
10-Year Return N/A
CHNA expense ratio is 0.79%.

CHNA holdings

Top 10 Holdings (37.76% of Total Assets)

Name Symbol % Assets
CanSino Biologics Inc Class H 06185 5.05%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 02269 4.04%
Wuxi AppTec Co Ltd 02359 3.9%
Sino Biopharmaceutical Ltd 01177.HK 3.84%
Hansoh Pharmaceutical Group Co Ltd 03692 3.79%
Shanghai Junshi Biosciences Co Ltd Class H 01877 3.63%
CK Life Sciences International Holdings Inc 00775.HK 3.47%
CSPC Pharmaceutical Group Ltd 01093.HK 3.38%
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H 02196 3.36%
Alphamab Oncology Ordinary Shares 09966 3.3%

Other relevant CHNA comparisons

You may also want to check out the following CHNA comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
    Follow Us